Better Weight Loss Stock: Novo Nordisk Vs. Amgen

2026-03-08 14:50:00 ET

The weight-loss market has become one of the most active therapeutic areas in the pharmaceutical industry over the past few years. And based on analyst projections, it will continue growing at a good clip for the foreseeable future.

Plenty of drugmakers are looking to gain a foothold in this market. Two of the most promising candidates are Novo Nordisk (NYSE: NVO) and Amgen (NASDAQ: AMGN) . But which one of these two giants is the better weight loss stock to buy right now? Let's find out.

Image source: Getty Images.

Continue reading